Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma.
about
Inflammatory breast cancer: clinical progress and the main problems that must be addressedUpdate on inflammatory breast cancerFirst description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three casesShort- and long-term cause-specific survival of patients with inflammatory breast cancer.Inflammatory breast cancer: what we know and what we need to learnUnderuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database.Locoregional treatment outcomes after multimodality management of inflammatory breast cancerPrimary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancerLong-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapyConcomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up.Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyPredictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation.Biology and management of inflammatory breast cancer.Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery.(18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy.How do I treat inflammatory breast cancer?
P2860
Q21195182-7A02C77B-D96D-426D-BDAB-0C28EA915538Q24797853-9BC475BA-0259-4F03-916C-B128AB770CBFQ24805938-FF6986B2-A457-4E32-A37F-BFBA4844F549Q24817154-EF9ABC06-DF54-4AC0-82F0-B8618A17E391Q27028128-F0A348E8-6AC4-465F-8807-37F5F1F0232AQ33796162-68FDE83C-7E40-4FEC-B20A-42CFB5C60F03Q34584856-C1A1562D-AFDE-4A18-BEEE-A3589876C3CEQ34782298-36A5150C-E50D-464D-B96E-D652621F1A89Q35129511-73655B56-E915-41F7-BB1A-70F6108595C7Q36611240-7640BA1C-9FBC-4755-AF38-D0372D1C9C2AQ37259756-5E6431C4-186A-4A91-9CA2-7B59696A7599Q37687112-C0DFE0E1-2ED6-4CF3-8F31-348AEB2B1A51Q37687382-DE41D301-AF80-48B4-9968-1256745C1832Q44158111-9CC74774-0E59-47DF-9916-E9E6F3A045CBQ44211796-AAFA5DC9-F8E9-4357-B21A-40D6BC6C6740Q44586994-540000E7-8112-4BE0-826A-D9EEA1066AAB
P2860
Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Effectiveness of mastectomy by ...... inflammatory breast carcinoma.
@en
type
label
Effectiveness of mastectomy by ...... inflammatory breast carcinoma.
@en
prefLabel
Effectiveness of mastectomy by ...... inflammatory breast carcinoma.
@en
P2093
P356
P1476
Effectiveness of mastectomy by ...... inflammatory breast carcinoma.
@en
P2093
Fleming RY
McNeese MD
Singletary SE
P2888
P304
P356
10.1007/BF02303668
P577
1997-09-01T00:00:00Z
P6179
1023443182